ARMP · Categories · Form 4

ARMP - SEC Form 4 insider transactions

Armata Pharmaceuticals Inc. (ARMP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ARMP

• 41d
  SEC Form 4 filed by Director Gilmer Daniel B.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 83d
  Chief Business Officer Kyme Pierre covered exercise/tax liability with 1,030 shares, decreasing direct ownership by 10% to 9,461 units (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 83d
  Chief Executive Officer Birx Deborah covered exercise/tax liability with 4,919 shares, decreasing direct ownership by 2% to 212,458 units (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 89d
  SEC Form 4 filed by Director Kramer Robin

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 89d
  SEC Form 4 filed by Chief Business Officer Kyme Pierre

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 89d
  SEC Form 4 filed by SVP, Finance, and PFO House David Duane

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 89d
  SEC Form 4 filed by Director Patti Joseph M

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 89d
  SEC Form 4 filed by Director Peterson Todd C.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 89d
  SEC Form 4 filed by Director Odysseas Kostas D

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 89d
  SEC Form 4 filed by Chief Executive Officer Birx Deborah

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 89d
  SEC Form 4 filed by Director Schlesinger Sarah J.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 89d
  SEC Form 4 filed by Director Haimovitz Jules

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 329d
  Chief Executive Officer Birx Deborah covered exercise/tax liability with 13,637 shares, decreasing direct ownership by 6% to 217,377 units (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 409d
  Chief Executive Officer Birx Deborah covered exercise/tax liability with 28,986 shares, decreasing direct ownership by 11% to 231,014 units (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 409d
  Chief Business Officer Kyme Pierre covered exercise/tax liability with 1,027 shares, decreasing direct ownership by 9% to 10,491 units (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 486d
  SEC Form 4 filed by Director Odysseas Kostas D

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 486d
  SEC Form 4 filed by Director Schlesinger Sarah J.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 486d
  SEC Form 4 filed by Director Peterson Todd C.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 486d
  SEC Form 4 filed by Director Patti Joseph M

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 486d
  SEC Form 4 filed by Chief Business Officer Kyme Pierre

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 486d
  SEC Form 4 filed by Director Kramer Robin

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 486d
  SEC Form 4 filed by SVP, Finance, and PFO House David Duane

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 486d
  SEC Form 4 filed by Director Haimovitz Jules

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 486d
  SEC Form 4 filed by Chief Executive Officer Birx Deborah

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 613d
  SEC Form 4 filed by SVP, Finance, and PFO House David Duane

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 812d
  SEC Form 4 filed by Patti Joseph M

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 812d
  SEC Form 4 filed by Kramer Robin

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 812d
  SEC Form 4 filed by Peterson Todd C.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 812d
  Rychlik Richard was granted 10,000 shares (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 812d
  SEC Form 4 filed by Schlesinger Sarah J.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 812d
  SEC Form 4 filed by Haimovitz Jules

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 812d
  SEC Form 4 filed by Odysseas Kostas D

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 812d
  Birx Deborah was granted 60,000 shares, increasing direct ownership by 30% to 260,000 units (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 895d
  SEC Form 4 filed by Schlesinger Sarah J.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 895d
  SEC Form 4 filed by Peterson Todd C.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 895d
  SEC Form 4 filed by Kramer Robin

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 895d
  SEC Form 4 filed by Patti Joseph M

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 895d
  SEC Form 4 filed by Rychlik Richard

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 895d
  SEC Form 4 filed by Haimovitz Jules

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 895d
  SEC Form 4 filed by Odysseas Kostas D

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 895d
  Birx Deborah was granted 200,000 shares (SEC Form 4)

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1515d
  SEC Form 4 filed by Peterson Todd C.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1515d
  SEC Form 4 filed by Patrick Todd

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1515d
  SEC Form 4 filed by Schlesinger Sarah J.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1515d
  SEC Form 4 filed by Kramer Robin

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1515d
  SEC Form 4 filed by Odysseas Kostas D

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1515d
  SEC Form 4 filed by Patti Joseph M

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1515d
  SEC Form 4 filed by Haimovitz Jules

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1515d
  SEC Form 4 filed by Morris Duane Alfred

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1515d
  SEC Form 4 filed by Varnum Brian

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1825d
  SEC Form 4 filed by Schlesinger Sarah J.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1825d
  SEC Form 4 filed by PATTI JOSEPH M

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1825d
  SEC Form 4 filed by Armata Pharmaceuticals, Inc.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1825d
  SEC Form 4 filed by Kramer Robin

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1825d
  SEC Form 4 filed by Armata Pharmaceuticals, Inc.

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1890d
  SEC Form 4 filed by Jules Haimovitz

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1900d
  SEC Form 4 filed by Brian Varnum

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1900d
  SEC Form 4 filed by Todd Patrick

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1900d
  SEC Form 4 filed by Alfred Duane Morris

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)
• 1900d
  SEC Form 4 filed by Robert Steven Martin

  4 - Armata Pharmaceuticals, Inc. (0000921114) (Issuer)

Other ARMP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends